Cutia Therapeutics (HKG:2487)

Cutia Therapeutics Revenue

Cutia Therapeutics had revenue of 62.71M CNY in the half year ending June 30, 2026, a decrease of -34.38%. This brings the company's revenue in the last twelve months to 332.58M, up 32.85% year-over-year. In the year 2025, Cutia Therapeutics had annual revenue of 336.15M with 20.22% growth.

• Revenue (ttm): 332.58M CNY
• Revenue Growth: +32.85%
• P/S Ratio: 1.14
• Revenue / Employee: 1.24M CNY
• Employees: 268
• Market Cap: 436.04M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	336.15M	56.54M	20.22%
Dec 31, 2024	279.62M	141.99M	103.17%
Dec 31, 2023	137.62M	126.26M	1,110.83%
Dec 31, 2022	11.37M	9.33M	457.70%
Dec 31, 2021	2.04M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 20, 2026

Data Sources Report a data error